|Petition Title||Change in limitation of 24 mg of buprenorphrine for addiction|
|Date Filed||12/2/2019 [Transmittal Sheet]|
|Petitioner||Dr. Lee Tannenbaum|
To amend subsection I of 18VAC85-21-150 to allow prescribing of up to the FDA approved limit of 32 mg QD.
In accordance with Virginia law, the petition will be filed with the Register of Regulations and published on December 23, 2019 and posted on the Virginia Regulatory Townhall at www.townhall.virginia.gov. Comment on the petition will be requested until January 22, 2020 and may be posted on the Townhall or sent to the Board.
Following receipt of all comments on the petition to amend regulations, the matter will be considered by the full Board at its meeting in February of 2020.
|Comment Period||Ended 1/22/2020 1 comments|
|Agency Decision||Take no action [Transmittal Sheet]|
|Agency Decision Summary||
Opposition to the change noted that the Federal Drug Administration and the American Society for Addiction Medicine support a maximum of 24 mg per day and that there is little evidence of further benefit from increasing the dosage. It was also noted that if a patient is unable to reach full recovery on 24 mg daily, it signals drug failure and other options must be considered.
|Name / Title:||William L. Harp, M.D. / Executive Director|
9960 Mayland Drive
|Telephone:||(804)367-4558 FAX: (804)527-4429 TDD: ()-|